Full name : O'Neill Michael J
First name : Michael J
Mail : Lilly UK, Erl Wood Manor, Windlesham, Surrey GU20 6PH
Zip Code :
City :
Country : United Kingdom
Email :
Phone :
Fax :
Website :
Directory :
Comment
Title : Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders - Bruns_2017_Neuropharmacol_128_351 |
Author(s) : Bruns RF , Mitchell SN , Wafford KA , Harper AJ , Shanks EA , Carter G , O'Neill MJ , Murray TK , Eastwood BJ , Schaus JM , Beck JP , Hao J , Witkin JM , Li X , Chernet E , Katner JS , Wang H , Ryder JW , Masquelin ME , Thompson LK , Love PL , Maren DL , Falcone JF , Menezes MM , Zhang L , Yang CR , Svensson KA |
Ref : Neuropharmacology , 128 :351 , 2017 |
Abstract : |
PubMedSearch : Bruns_2017_Neuropharmacol_128_351 |
PubMedID: 29102759 |
Title : AMPA receptor potentiators as cognitive enhancers - O'Neill_2007_IDrugs_10_185 |
Author(s) : O'Neill MJ , Dix S |
Ref : IDrugs , 10 :185 , 2007 |
Abstract : |
PubMedSearch : O'Neill_2007_IDrugs_10_185 |
PubMedID: 17351873 |
Title : Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes - Jones_2006_J.Mol.Neurosci_30_83 |
Author(s) : Jones IW , Westmacott A , Chan E , Jones RW , Dineley K , O'Neill MJ , Wonnacott S |
Ref : Journal of Molecular Neuroscience , 30 :83 , 2006 |
Abstract : |
PubMedSearch : Jones_2006_J.Mol.Neurosci_30_83 |
PubMedID: 17192639 |
Title : Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat - Visanji_2006_Neuropharmacol_50_36 |
Author(s) : Visanji NP , Mitchell SN , O'Neill MJ , Duty S |
Ref : Neuropharmacology , 50 :36 , 2006 |
Abstract : |
PubMedSearch : Visanji_2006_Neuropharmacol_50_36 |
PubMedID: 16153666 |
Title : Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle - Visanji_2006_Neuropharmacol_51_506 |
Author(s) : Visanji NP , O'Neill MJ , Duty S |
Ref : Neuropharmacology , 51 :506 , 2006 |
Abstract : |
PubMedSearch : Visanji_2006_Neuropharmacol_51_506 |
PubMedID: 16814329 |
Title : 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta - Hanrott_2006_J.Biol.Chem_281_5373 |
Author(s) : Hanrott K , Gudmunsen L , O'Neill MJ , Wonnacott S |
Ref : Journal of Biological Chemistry , 281 :5373 , 2006 |
Abstract : |
PubMedSearch : Hanrott_2006_J.Biol.Chem_281_5373 |
PubMedID: 16361258 |
Title : SMi 4th Annual Conference on Neurodegenerative Disorders: a focus on Alzheimer's and Parkinson's disease - O'Neill_2004_Expert.Opin.Investig.Drugs_13_1369 |
Author(s) : O'Neill MJ |
Ref : Expert Opin Investig Drugs , 13 :1369 , 2004 |
Abstract : |
PubMedSearch : O'Neill_2004_Expert.Opin.Investig.Drugs_13_1369 |
PubMedID: 15461566 |
Title : Alpha bungarotoxin-1.4 nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7* nicotinic acetylcholine receptors - Jones_2004_J.Neurosci.Methods_134_65 |
Author(s) : Jones IW , Barik J , O'Neill MJ , Wonnacott S |
Ref : Journal of Neuroscience Methods , 134 :65 , 2004 |
Abstract : |
PubMedSearch : Jones_2004_J.Neurosci.Methods_134_65 |
PubMedID: 15102504 |
Title : The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration - O'Neill_2002_Curr.Drug.Targets.CNS.Neurol.Disord_1_399 |
Author(s) : O'Neill MJ , Murray TK , Lakics V , Visanji NP , Duty S |
Ref : Curr Drug Targets CNS Neurol Disord , 1 :399 , 2002 |
Abstract : |
PubMedSearch : O'Neill_2002_Curr.Drug.Targets.CNS.Neurol.Disord_1_399 |
PubMedID: 12769612 |
Title : Pharmacological approaches to disease-modifying therapies in Parkinson's disease - O'Neill_2002_Expert.Rev.Neurother_2_819 |
Author(s) : O'Neill MJ , Siemers ER |
Ref : Expert Rev Neurother , 2 :819 , 2002 |
Abstract : |
PubMedSearch : O'Neill_2002_Expert.Rev.Neurother_2_819 |
PubMedID: 19810916 |